March 18, 2002Catheterization and Cardiovascular Interventions
Stenting of bifurcation lesions using the bestent: A prospective dual‐center study
Key result
Bestent implantation for bifurcation lesions achieved 100% procedural success in the main branch, with a 14.6% rate of major cardiac and cerebral events at 6-month follow-up.
Why the study?
Does the Bestent improve procedural success and clinical outcomes in patients with bifurcation lesions?
Population
96 patients with bifurcation lesions involving a side branch >= 2.2 mm in diameter, mean age 63.7 +/- 11.4…
Design
Cohort
Follow-up
6 months
Authors
Discussion
Loading...
Member takes
Implication
Supports Bestent feasibility in bifurcations; hypothesis-generating and should not yet change practice.
Study Design
Type
Cohort (n=96)
Multicenter
Yes
Structured PICO
Does the Bestent improve procedural success and clinical outcomes in patients with bifurcation lesions?
P
Population
96 patients (mean age 63.7 years, 81.3% male) with bifurcation lesions involving a side branch ≥ 2.2 mm in diameter, followed for 6 months.
E
Exposure
Bestent implanted in the main branch or both branches (T-stenting or provisional T-stenting used in 88% of cases, final kissing balloon inflation in 78%).
O
Outcome
Procedural success and Major cardiac and cerebral events (MACCE) at 6-month follow-upcomposite
The Bestent, using a provisional T-stenting strategy, provides high procedural success and acceptable 6-month clinical outcomes for coronary bifurcation lesions.
Cite This Study
Gobeil et al. (2002) conducted a cohort in Bifurcation lesions (n=96). Bestent implantation was evaluated on Major cardiac and cerebral events (MACCE) at 6 months. Bestent implantation for bifurcation lesions achieved 100% procedural success in the main branch, with a 14.6% rate of major cardiac and cerebral events at 6-month follow-up.